KR20150102852A - 무정형 솔리페나신 또는 그의 염을 포함하는 안정성이 증가된 고체분산체 조성물 및 그 제조방법 - Google Patents

무정형 솔리페나신 또는 그의 염을 포함하는 안정성이 증가된 고체분산체 조성물 및 그 제조방법 Download PDF

Info

Publication number: KR20150102852A
Authority: KR; South Korea
Prior art keywords: solifenacin; solid dispersion; pharmaceutically acceptable; amorphous; dispersion composition
Prior art date: 2014-02-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

KR1020140024747A

Other languages

English (en)

Korean (ko)

Inventor

유용원

강세연

송세현

손세일

이홍우

Original Assignee

대원제약주식회사

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-02-28

Filing date

2014-02-28

Publication date

2015-09-08

2014-02-28 Application filed by 대원제약주식회사 filed Critical 대원제약주식회사

2014-02-28 Priority to KR1020140024747A priority Critical patent/KR20150102852A/ko

2015-02-26 Priority to PCT/KR2015/001891 priority patent/WO2015130110A1/fr

2015-09-08 Publication of KR20150102852A publication Critical patent/KR20150102852A/ko

Status Withdrawn legal-status Critical Current

Links

Images

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Urology & Nephrology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

KR1020140024747A 2014-02-28 2014-02-28 무정형 솔리페나신 또는 그의 염을 포함하는 안정성이 증가된 고체분산체 조성물 및 그 제조방법 Withdrawn KR20150102852A (ko)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
KR1020140024747A KR20150102852A (ko)	2014-02-28	2014-02-28	무정형 솔리페나신 또는 그의 염을 포함하는 안정성이 증가된 고체분산체 조성물 및 그 제조방법
PCT/KR2015/001891 WO2015130110A1 (fr)	2014-02-28	2015-02-26	Composition de dispersion solide à stabilité accrue, contenant de la solifénacine amorphe ou un sel de celui-ci, et son procédé de préparation

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
KR1020140024747A KR20150102852A (ko)	2014-02-28	2014-02-28	무정형 솔리페나신 또는 그의 염을 포함하는 안정성이 증가된 고체분산체 조성물 및 그 제조방법

Publications (1)

Publication Number	Publication Date
KR20150102852A true KR20150102852A (ko)	2015-09-08

Family

ID=54009361

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
KR1020140024747A Withdrawn KR20150102852A (ko)	2014-02-28	2014-02-28	무정형 솔리페나신 또는 그의 염을 포함하는 안정성이 증가된 고체분산체 조성물 및 그 제조방법

Country Status (2)

Country	Link
KR (1)	KR20150102852A (fr)
WO (1)	WO2015130110A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2017082577A1 (fr) *	2015-11-11	2017-05-18	한미약품 주식회사	Préparation solide contenant de la solifénacine amorphe à usage oral et son procédé de préparation
WO2018004270A1 (fr) *	2016-06-30	2018-01-04	한미약품 주식회사	Préparation solide administrée par voie orale contenant de la solifénacine amorphe et son procédé de préparation
KR20210114271A (ko)	2020-03-10	2021-09-23	주식회사 종근당	솔리페나신 또는 이의 약제학적으로 허용가능한 염을 함유하는 약제학적 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20100137358A1 (en) *	1996-11-05	2010-06-03	Dr. Reddy's Laboratories Ltd.	Solifenacin compositions
KR101836467B1 (ko) *	2004-03-25	2018-03-08	아스텔라스세이야쿠 가부시키가이샤	솔리페나신 또는 그의 염의 고형 제제용 조성물

2014
- 2014-02-28 KR KR1020140024747A patent/KR20150102852A/ko not_active Withdrawn
2015
- 2015-02-26 WO PCT/KR2015/001891 patent/WO2015130110A1/fr not_active Ceased

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2017082577A1 (fr) *	2015-11-11	2017-05-18	한미약품 주식회사	Préparation solide contenant de la solifénacine amorphe à usage oral et son procédé de préparation
WO2018004270A1 (fr) *	2016-06-30	2018-01-04	한미약품 주식회사	Préparation solide administrée par voie orale contenant de la solifénacine amorphe et son procédé de préparation
KR20210114271A (ko)	2020-03-10	2021-09-23	주식회사 종근당	솔리페나신 또는 이의 약제학적으로 허용가능한 염을 함유하는 약제학적 조성물
KR20230065222A (ko)	2020-03-10	2023-05-11	주식회사 종근당	솔리페나신 또는 이의 약제학적으로 허용가능한 염을 함유하는 약제학적 조성물

Also Published As

Publication number	Publication date
WO2015130110A1 (fr)	2015-09-03

Similar Documents

Publication	Publication Date	Title
KR101836467B1 (ko)	2018-03-08	솔리페나신 또는 그의 염의 고형 제제용 조성물
EP3417861B1 (fr)	2020-09-23	Composition pharmaceutique contenant un inhibiteur de janus kinase (jak) ou un sel pharmaceutiquement acceptable de celui-ci
KR101977785B1 (ko)	2019-05-14	에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제 및 그 제조방법
AU2016378482A1 (en)	2018-07-12	Pharmaceutical composition comprising amorphous lenalidomide and an antioxidant
CN107949375B (zh)	2023-04-21	含有伊立替康的口服固体制剂及其制备方法
EP2415472A1 (fr)	2012-02-08	Composition pharmaceutique solide contenant un corps amorphe de solifénacine
ES2326529T3 (es)	2009-10-14	Composicion farmaceutica que contiene una forma amorfa estabilizada de clorhidrato de donepezil.
EA024945B1 (ru)	2016-11-30	Композиции на основе налбуфина и их применение
RS64377B1 (sr)	2023-08-31	Tableta koja sadrži derivat metoksiuree i čestice manitola
ES2940306T3 (es)	2023-05-05	Composición farmacéutica estable para administración oral
US10583087B2 (en)	2020-03-10	Pharmaceutical composition for oral administration
US20180000792A1 (en)	2018-01-04	Modified release compositions of epalrestat or a derivative thereof and methods for using the same
US20210244732A1 (en)	2021-08-12	Packaging body of pharmaceutical composition containing antitumor agent
KR20150102852A (ko)	2015-09-08	무정형 솔리페나신 또는 그의 염을 포함하는 안정성이 증가된 고체분산체 조성물 및 그 제조방법
KR101476011B1 (ko)	2014-12-23	경구 투여용 의약 조성물
EP3603643B1 (fr)	2021-09-15	Composition médicinale en comprimés comprenant de la nalfurafine
EP3875090A1 (fr)	2021-09-08	Granule contenant un agent antitumoral
KR100555794B1 (ko)	2006-03-03	이트라코나졸을 함유하는 경구용 조성물
EP2803352B1 (fr)	2018-08-01	Compositions d'imatinib
KR20140125492A (ko)	2014-10-29	몬테루카스트 나트륨염 함유 과립 조성물의 제조방법
WO2024143236A1 (fr)	2024-07-04	Cristaux de chlorhydrate d'acétate
JP2022151564A (ja)	2022-10-07	薬効成分としてビルダグリプチンおよびメトホルミンを含む錠剤
KR20150042561A (ko)	2015-04-21	위장질환 치료용 약학적 조성물
KR20110136074A (ko)	2011-12-21	안정한 에스-베포타스틴 함유 약학조성물 및 이의 제조방법
HK40048975A (en)	2021-12-10	Package for medical composition containing anti-tumor agent

Legal Events

Date	Code	Title	Description
2014-02-28	PA0109	Patent application	St.27 status event code: A-0-1-A10-A12-nap-PA0109
2014-03-25	PN2301	Change of applicant	St.27 status event code: A-3-3-R10-R13-asn-PN2301 St.27 status event code: A-3-3-R10-R11-asn-PN2301
2014-03-25	R18-X000	Changes to party contact information recorded	St.27 status event code: A-3-3-R10-R18-oth-X000
2015-09-08	PG1501	Laying open of application	St.27 status event code: A-1-1-Q10-Q12-nap-PG1501
2019-04-01	PC1203	Withdrawal of no request for examination	St.27 status event code: N-1-6-B10-B12-nap-PC1203
2019-04-01	WITN	Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid
2021-12-08	PN2301	Change of applicant	St.27 status event code: A-3-3-R10-R13-asn-PN2301 St.27 status event code: A-3-3-R10-R11-asn-PN2301
2024-02-23	R18-X000	Changes to party contact information recorded	St.27 status event code: A-3-3-R10-R18-oth-X000
2025-06-30	PN2301	Change of applicant	St.27 status event code: A-3-3-R10-R13-asn-PN2301 St.27 status event code: A-3-3-R10-R11-asn-PN2301
2025-09-26	R18	Changes to party contact information recorded	Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)
2025-09-26	R18-X000	Changes to party contact information recorded	St.27 status event code: A-3-3-R10-R18-oth-X000
2025-10-13	R18	Changes to party contact information recorded	Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)
2025-10-13	R18-X000	Changes to party contact information recorded	St.27 status event code: A-3-3-R10-R18-oth-X000
2025-12-02	R18	Changes to party contact information recorded	Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)
2025-12-02	R18-X000	Changes to party contact information recorded	St.27 status event code: A-3-3-R10-R18-oth-X000
2026-01-05	R18	Changes to party contact information recorded	Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)
2026-01-05	R18-X000	Changes to party contact information recorded	St.27 status event code: A-3-3-R10-R18-oth-X000